MarketsandMarkets

Sleep Apnea Oral Appliances Market 2023: Investigating Research Trends, Industry Expansion, and Projections for 2028

In 2023, Vivos Therapeutics, Inc. (US) DNA appliance was granted 510(k) clearance from the U.S. Food & Drug Administration (or FDA) as a Class II medical device in December 2022 for the treatment of snoring and mild to moderate OSA in adults.

 

Northbrook, IL 60062 -- (SBWIRE) -- 01/17/2024 -- Sleep Apnea Oral Appliances Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028 according to a new report by MarketsandMarkets. The growth of this market is majorly driven by the high risk of growing awarrness and diagnosis of sleep apnea among patients and healthcare professionals. Furthermore, the poor compliance associated with CPAP is expected to drive the growth of the sleep apnea oral appliances market.

Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105423877

Browse in-depth TOC on "Sleep Apnea Oral Appliances Market"

150 - Tables
40 - Figures
180 – Pages

The mandibular advancement devices segment is expected to account for the largest share in 2022.

Mandibular advamcement devices force the lower jaw forward and downwards slightly, which keeps the airway open. The device helps treat OSA by offering maximum anterior tongue space along with the retention of teeth movement. This segment is expected to dominate the global sleep apnea oral appliances market during the forecast period, driven by a rising patient preference for non-CPAP solutions due comfort and ease of use.

The fertility clinics segment held the largest market share in the sleep apnea oral appliances market.

By end user, the global sleep apnea oral appliances market is broadly segmented into home care settings/individuals, hospitals, and dental clinics. The large share of this segment can be attributed to factors such as the increasing number of sleep centers globally, the rise of number of sleep care devices for homecare settings offered by leading players.

North America dominates the global sleep apnea oral appliances market.

Based on the region, the sleep apnea oral appliances market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American market is driven by high prevalence and diagnosis of sleep apnea in the region. Europe is the second-largest market for the sleep apnea oral appliances market due to the growing aging population in the region. Asia Pacific will observe high growth during the forecast period with its growing healthcare expenditure with improving accessibility to sleep clinics and treatment for sleep apnea in the region's countries.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=105423877

Sleep Apnea Oral Appliances Market Dynamics:

Drivers:

1. Large pool of undiagnosed sleep apnea patients

Restraints:

1. Associated risks of oral appliances for obstructive sleep apnea treatment

Opportunities:

1. Poor compliance associated with CPAP

Challenge:

1. Expenses associated with customization of oral appliances

Key Market Players of Sleep Apnea Oral Appliances Industry:

Major players in the sleep apnea oral appliances market include SonmoMed (Australia), resMed (US), Whole You, Inc. (US), ProSomnus Sleep Technologies (US), and Vivos Therapeutics, Inc. (US).

Breakdown of supply-side primary interviews, by company type, designation, and region:

- By Company Type: Tier 1 (40%), Tier 2 (50%), and Tier 3 (10%)
- By Designation: C-level (48%), Director-level (37%), and Others (15%)
- By Region: North America (56%), Europe (20%), Asia- Pacific (17%), and Rest of the World (7%)

Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=105423877

Sleep Apnea Oral Appliances Market Recent Developments:

- In 2023, Vivos Therapeutics, Inc. (US) DNA appliance was granted 510(k) clearance from the U.S. Food & Drug Administration (or FDA) as a Class II medical device in December 2022 for the treatment of snoring and mild to moderate OSA in adults.

- In 2022, ResMed (US) acquired the German-based clinical, financial, and operational solutions provider MEDIFOX DAN (Germany) to drive leadership in out-of-hospital software solutions.

- In 2021, SomoMed (Australia) conducted SomSUMMIT '21, which aimed to enhance research, education, and awareness of oral appliance therapy as a primary solution to successful OSA treatment.

Sleep Apnea Oral Appliances Market - Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall sleep apnea oral appliance market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com